Cargando…

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction

In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2010. The incidence of Invasive Meningococcal Disease (IMD) was 0.25 confirmed cases per 100,000 in 2011, but this may be considerably underestimated due to underdetection and underreporting. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Domenico, Fortunato, Francesca, Cappelli, Maria Giovanna, Cozza, Vanessa, Chironna, Maria, Prato, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553333/ https://www.ncbi.nlm.nih.gov/pubmed/26351649 http://dx.doi.org/10.1155/2015/710656

Ejemplares similares

Four-Component Recombinant Protein–Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy
por: Lodi, Lorenzo, et al.
Publicado: (2023)

Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives
por: SIGNORELLI, C., et al.
Publicado: (2015)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case–control study in a 2-year prospective cohort
por: Prato, Rosa, et al.
Publicado: (2018)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019)
por: Riccò, Matteo, et al.
Publicado: (2023)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008)

Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
por: Neri, Arianna, et al.
Publicado: (2022)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Are physicians obligated to tell parents about the meningococcal serogroup B vaccine?
por: Robinson, Dr Joan L
Publicado: (2015)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
por: Srivastava, Amit, et al.
Publicado: (2020)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
por: Johnson, Reed, et al.
Publicado: (2020)

A comparison of national vaccination policies to prevent serogroup B meningococcal disease
por: Sulis, Giorgia, et al.
Publicado: (2022)

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Folaranmi, Temitope, et al.
Publicado: (2015)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
por: Soeters, Heidi M., et al.
Publicado: (2017)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines
por: Sullivan, Christopher B., et al.
Publicado: (2015)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
por: Biolchi, Alessia, et al.
Publicado: (2019)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
por: Sáfadi, Marco Aurelio Palazzi, et al.
Publicado: (2014)

Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme
por: Gonçalves, Paulo, et al.
Publicado: (2021)

Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
por: Marjuki, Henju, et al.
Publicado: (2019)

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
por: de Voer, Richarda M., et al.
Publicado: (2010)

Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines
por: Sullivan, Christopher B., et al.
Publicado: (2015)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ru1iq4vsndu7j7a6nvkrbmvv8e